Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2014

01-10-2014

The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database

Authors: Atsuhiko Murata, Kohji Okamoto, Toshihiko Mayumi, Keiji Muramatsu, Shinya Matsuda

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2014

Login to get access

Abstract

The aim of this study is to investigate the recent trend over time of outcomes of patients with disseminated intravascular coagulation (DIC) based on the Japanese administrative database. A total of 34,711 patients with DIC had been referred to 1,092 hospitals from 2010 to 2012 in Japan. We collected patients’ data from the administrative database to compare in-hospital mortality within 14 and 28 days between periods. The study periods were categorized into three groups: 2010 (n = 8,382), 2011 (n = 13,372), and 2012 (n = 12,957). These analyses were performed according to the underlying diseases associated with DIC. The in-hospital mortality within 14 or 28 days of DIC patients with infectious diseases decreased between 2010 and 2012 (within 14 days: 20.4 vs. 18.1 vs. 17.9 %, P = 0.009; within 28 days: 31.1 vs. 28.7 vs. 27.7 %, P = 0.003; respectively). Multiple logistic regressions also showed that the period was associated with in-hospital mortality of DIC patients with infectious diseases. The odds ratios of 2011 and 2012 for in-hospital mortality within 14 days were 0.86 [95 % confidence intervals (CI) 0.77–0.97] and 0.84 (95 % CI 0.75–0.94) whereas those for in-hospital mortality within 28 days were 0.89 (95 % CI 0.81–0.98) and 0.83 (95 % CI 0.76–0.92), respectively. However, there were no significant differences in mortality of patients with DIC associated with other underlying diseases between 2010 and 2012. This study demonstrated that in-hospital mortality of DIC patients with infectious diseases gradually improved between 2010 and 2012 in Japan.
Literature
1.
go back to reference Levi M (2010) Current concepts in the management of disseminated intravascular coagulation. Semin Thromb Hemost 36:363–365PubMedCrossRef Levi M (2010) Current concepts in the management of disseminated intravascular coagulation. Semin Thromb Hemost 36:363–365PubMedCrossRef
2.
go back to reference Levi M, van der Poll T (2013) Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med 8:23–32PubMedCrossRef Levi M, van der Poll T (2013) Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med 8:23–32PubMedCrossRef
3.
go back to reference Okajima K, Sakamoto Y, Uchiba M (2000) Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol 65:215–222PubMedCrossRef Okajima K, Sakamoto Y, Uchiba M (2000) Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases. Am J Hematol 65:215–222PubMedCrossRef
4.
go back to reference Sivula M, Tallgren M, Pettilä V (2005) Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med 31:1209–1214PubMedCrossRef Sivula M, Tallgren M, Pettilä V (2005) Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med 31:1209–1214PubMedCrossRef
5.
go back to reference Toh CH, Downey C (2005) Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 16:69–74PubMedCrossRef Toh CH, Downey C (2005) Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 16:69–74PubMedCrossRef
6.
go back to reference Angstwurm MW, Dempfle CE, Spannagl M (2006) New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34:314–320PubMedCrossRef Angstwurm MW, Dempfle CE, Spannagl M (2006) New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34:314–320PubMedCrossRef
7.
go back to reference Wiinberg B, Jensen AL, Johansson PI et al (2010) Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity. Vet J 185:292–298PubMedCrossRef Wiinberg B, Jensen AL, Johansson PI et al (2010) Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity. Vet J 185:292–298PubMedCrossRef
8.
go back to reference Iba T, Nagaoka I, Boulat M (2013) The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation. Thromb Res 131:383–389PubMedCrossRef Iba T, Nagaoka I, Boulat M (2013) The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation. Thromb Res 131:383–389PubMedCrossRef
9.
go back to reference Vincent JL, Ramesh MK, Ernest D et al (2013) A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41:2069–2079PubMedCrossRef Vincent JL, Ramesh MK, Ernest D et al (2013) A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41:2069–2079PubMedCrossRef
10.
go back to reference Nakagawa M, Tsuji H (1999) Current trends in the diagnosis of disseminated intravascular coagulation in Japan: findings of questionnaire survey. Rinsho Ketsueki 40:362–364PubMed Nakagawa M, Tsuji H (1999) Current trends in the diagnosis of disseminated intravascular coagulation in Japan: findings of questionnaire survey. Rinsho Ketsueki 40:362–364PubMed
11.
go back to reference Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP (2003) Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect 47:300–306PubMedCrossRef Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP (2003) Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect 47:300–306PubMedCrossRef
12.
go back to reference Cartin-Ceba R, Kojicic M, Li G et al (2011) Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community. Chest 140:1447–1455PubMedCrossRef Cartin-Ceba R, Kojicic M, Li G et al (2011) Epidemiology of critical care syndromes, organ failures, and life-support interventions in a suburban US community. Chest 140:1447–1455PubMedCrossRef
13.
go back to reference Rattray DD, O’Connell CM, Baskett TF (2012) Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 34:341–347PubMed Rattray DD, O’Connell CM, Baskett TF (2012) Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 34:341–347PubMed
14.
go back to reference Krigsfeld GS, Kennedy AR (2013) Is disseminated intravascular coagulation the major cause of mortality from radiation at relatively low whole body doses? Radiat Res 180:231–234PubMedCrossRef Krigsfeld GS, Kennedy AR (2013) Is disseminated intravascular coagulation the major cause of mortality from radiation at relatively low whole body doses? Radiat Res 180:231–234PubMedCrossRef
15.
go back to reference Murata A, Matsuda S, Kuwabara K et al (2011) An observational study using a national administrative database to determine the impact of hospital volume on compliance with clinical practice guidelines. Med Care 49:313–320PubMedCrossRef Murata A, Matsuda S, Kuwabara K et al (2011) An observational study using a national administrative database to determine the impact of hospital volume on compliance with clinical practice guidelines. Med Care 49:313–320PubMedCrossRef
16.
go back to reference Murata A, Matsuda S, Mayumi T et al (2011) Effect of hospital volume on clinical outcome in patients with acute pancreatitis, based on a national administrative database. Pancreas 40:1018–1023PubMedCrossRef Murata A, Matsuda S, Mayumi T et al (2011) Effect of hospital volume on clinical outcome in patients with acute pancreatitis, based on a national administrative database. Pancreas 40:1018–1023PubMedCrossRef
17.
go back to reference Murata A, Matsuda S, Mayumi T et al (2012) Multivariate analysis of factors influencing medical costs of acute pancreatitis hospitalizations based on a national administrative database. Dig Liver Dis 44:143–148PubMedCrossRef Murata A, Matsuda S, Mayumi T et al (2012) Multivariate analysis of factors influencing medical costs of acute pancreatitis hospitalizations based on a national administrative database. Dig Liver Dis 44:143–148PubMedCrossRef
18.
go back to reference Murata A, Matsuda S, Kuwabara K et al (2013) Association between hospital volume and clinical outcomes of elderly patients with acute biliary diseases: a national administrative database analysis. Geriatr Gerontol Int 13:731–740PubMedCrossRef Murata A, Matsuda S, Kuwabara K et al (2013) Association between hospital volume and clinical outcomes of elderly patients with acute biliary diseases: a national administrative database analysis. Geriatr Gerontol Int 13:731–740PubMedCrossRef
19.
go back to reference Thachil J, Toh CH (2012) Current concepts in the management of disseminated intravascular coagulation. Thromb Res 129:S54–S59PubMedCrossRef Thachil J, Toh CH (2012) Current concepts in the management of disseminated intravascular coagulation. Thromb Res 129:S54–S59PubMedCrossRef
20.
go back to reference Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R (2006) Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 83:1039–1046PubMed Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R (2006) Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 83:1039–1046PubMed
21.
go back to reference Nielsen NM, Hansen AV, Simonsen J, Hviid A (2011) Prenatal stress and risk of infectious diseases in offspring. Am J Epidemiol 173:990–997PubMedCrossRef Nielsen NM, Hansen AV, Simonsen J, Hviid A (2011) Prenatal stress and risk of infectious diseases in offspring. Am J Epidemiol 173:990–997PubMedCrossRef
22.
go back to reference Asina S, Nakata T (2008) Quantitative analysis of energy-efficiency strategy on CO2 emissions in the residential sector in Japan—case study of Iwate prefecture. Appl Energy 85:204–217CrossRef Asina S, Nakata T (2008) Quantitative analysis of energy-efficiency strategy on CO2 emissions in the residential sector in Japan—case study of Iwate prefecture. Appl Energy 85:204–217CrossRef
23.
go back to reference Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97PubMedCrossRef Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97PubMedCrossRef
24.
go back to reference Sawamura A, Gando S, Hayakawa M, Hoshino H, Kubota N, Sugano M (2009) Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness. Clin Appl Thromb Hemost 15:561–566PubMedCrossRef Sawamura A, Gando S, Hayakawa M, Hoshino H, Kubota N, Sugano M (2009) Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness. Clin Appl Thromb Hemost 15:561–566PubMedCrossRef
25.
go back to reference Feng P, Zhou XH, Zou QM, Fan MY, Li XS (2012) Generalized propensity score for estimating the average treatment effect of multiple treatments. Stat Med 31:681–697PubMed Feng P, Zhou XH, Zou QM, Fan MY, Li XS (2012) Generalized propensity score for estimating the average treatment effect of multiple treatments. Stat Med 31:681–697PubMed
26.
go back to reference Mazzaglia G, Ambrosioni E, Alacqua M et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120:1598–1605PubMedCrossRef Mazzaglia G, Ambrosioni E, Alacqua M et al (2009) Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 120:1598–1605PubMedCrossRef
27.
go back to reference Murata A, Okamoto K, Muramatsu K, Kubo T, Fujino Y, Matsuda S (2014) Effects of additional laparoscopic cholecystectomy on outcomes of laparoscopic gastrectomy in patients with gastric cancer based on a national administrative database. J Surg Res 186:157–163PubMedCrossRef Murata A, Okamoto K, Muramatsu K, Kubo T, Fujino Y, Matsuda S (2014) Effects of additional laparoscopic cholecystectomy on outcomes of laparoscopic gastrectomy in patients with gastric cancer based on a national administrative database. J Surg Res 186:157–163PubMedCrossRef
28.
go back to reference Singh B, Hanson AC, Alhurani R et al (2013) Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004–2010): a population-based study. Chest 143:1235–1242PubMedCrossRef Singh B, Hanson AC, Alhurani R et al (2013) Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004–2010): a population-based study. Chest 143:1235–1242PubMedCrossRef
29.
go back to reference Wada H, Asakura H, Okamoto K et al (2010) Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 125:6–11PubMedCrossRef Wada H, Asakura H, Okamoto K et al (2010) Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 125:6–11PubMedCrossRef
30.
go back to reference Gando S, Wada H, Asakura H et al (2005) Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 11:71–76PubMedCrossRef Gando S, Wada H, Asakura H et al (2005) Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 11:71–76PubMedCrossRef
31.
go back to reference Wada H, Matsumoto T, Hatada T (2012) Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. Expert Rev Hematol 5:643–652PubMedCrossRef Wada H, Matsumoto T, Hatada T (2012) Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. Expert Rev Hematol 5:643–652PubMedCrossRef
32.
go back to reference Kato T, Sakai T, Kato M et al (2013) Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study. Thromb J 11:3PubMedCentralPubMedCrossRef Kato T, Sakai T, Kato M et al (2013) Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study. Thromb J 11:3PubMedCentralPubMedCrossRef
33.
go back to reference Yamakawa K, Ogura H, Fujimi S et al (2013) Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med 39:644–652PubMedCentralPubMedCrossRef Yamakawa K, Ogura H, Fujimi S et al (2013) Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med 39:644–652PubMedCentralPubMedCrossRef
34.
go back to reference Mimuro J, Takahashi H, Kitajima I et al (2013) Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation. Thromb Res 131:436–443PubMedCrossRef Mimuro J, Takahashi H, Kitajima I et al (2013) Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation. Thromb Res 131:436–443PubMedCrossRef
35.
go back to reference Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145:24–33PubMedCrossRef Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145:24–33PubMedCrossRef
36.
go back to reference Di Nisio M, Baudo F, Cosmi B et al (2012) Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 129:e177–e184PubMedCrossRef Di Nisio M, Baudo F, Cosmi B et al (2012) Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 129:e177–e184PubMedCrossRef
37.
go back to reference Iba T, Asakura H (2010) Comparison between British and Japanese guidelines for the diagnosis and treatment of disseminated intravascular coagulation. Br J Haematol 149:461–462PubMedCrossRef Iba T, Asakura H (2010) Comparison between British and Japanese guidelines for the diagnosis and treatment of disseminated intravascular coagulation. Br J Haematol 149:461–462PubMedCrossRef
Metadata
Title
The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database
Authors
Atsuhiko Murata
Kohji Okamoto
Toshihiko Mayumi
Keiji Muramatsu
Shinya Matsuda
Publication date
01-10-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-014-1068-3

Other articles of this Issue 3/2014

Journal of Thrombosis and Thrombolysis 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.